EOI Block Versus ESP Block in Laparoscopic Bariatric Surgery

Launched by CAIRO UNIVERSITY · Dec 5, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring two different methods of providing anesthesia—called EOI block and ESP block—during laparoscopic bariatric surgery, which is a type of weight-loss surgery. Researchers want to find out which method helps reduce the amount of pain medication (opioids) needed during the surgery and how well each method controls pain in the first 24 hours after the surgery. The goal is to see which technique leads to better pain management and less need for extra pain relief medications after the procedure.

To participate in this study, you need to be an adult between the ages of 18 and 70 with a body mass index (BMI) of 35 or higher, and have other health issues or a BMI of 40 or higher. You will be scheduled for specific types of weight-loss surgery, like sleeve gastrectomy or Roux-en-Y gastric bypass. However, if you have certain health conditions, such as severe liver or kidney problems, or if you are allergic to local anesthetics, you won't be able to take part in this trial. If you join, you can expect to receive one of the two anesthesia techniques and help researchers learn more about pain management in bariatric surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Obese patients of any gender with a body mass index (BMI) of ≥ 35 kg/m2 with comorbidities or \> 40 kg/m2 and American Society of Anesthesiologists (ASA) physical status I-III and aged between 18 and 70 years scheduled for laparoscopic bariatric surgery, that is, sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgery.
• Exclusion Criteria:
• • Coagulopathy, infection at the injection site, allergy to local anesthetics, severe hepatic or renal disease, severe cardiopulmonary disease (≥ ASA IV), diabetic or other neuropathies, patients receiving opioids for chronic analgesic therapy, and inability to comprehend visual analogue scale (VAS).